chr12-109586736-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000431.4(MVK):​c.632-18A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.251 in 1,612,244 control chromosomes in the GnomAD database, including 52,002 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5181 hom., cov: 33)
Exomes 𝑓: 0.25 ( 46821 hom. )

Consequence

MVK
NM_000431.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -5.96

Publications

17 publications found
Variant links:
Genes affected
MVK (HGNC:7530): (mevalonate kinase) This gene encodes the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
MVK Gene-Disease associations (from GenCC):
  • porokeratosis 3, disseminated superficial actinic type
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hyperimmunoglobulinemia D with periodic fever
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • mevalonic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • disseminated superficial actinic porokeratosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • porokeratosis of Mibelli
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-109586736-A-G is Benign according to our data. Variant chr12-109586736-A-G is described in ClinVar as Benign. ClinVar VariationId is 138312.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.306 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MVKNM_000431.4 linkc.632-18A>G intron_variant Intron 6 of 10 ENST00000228510.8 NP_000422.1 Q03426B2RDU6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MVKENST00000228510.8 linkc.632-18A>G intron_variant Intron 6 of 10 1 NM_000431.4 ENSP00000228510.3 Q03426

Frequencies

GnomAD3 genomes
AF:
0.255
AC:
38785
AN:
152014
Hom.:
5177
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.311
Gnomad AMI
AF:
0.330
Gnomad AMR
AF:
0.207
Gnomad ASJ
AF:
0.250
Gnomad EAS
AF:
0.165
Gnomad SAS
AF:
0.174
Gnomad FIN
AF:
0.166
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.258
Gnomad OTH
AF:
0.261
GnomAD2 exomes
AF:
0.230
AC:
57672
AN:
251140
AF XY:
0.230
show subpopulations
Gnomad AFR exome
AF:
0.310
Gnomad AMR exome
AF:
0.183
Gnomad ASJ exome
AF:
0.252
Gnomad EAS exome
AF:
0.172
Gnomad FIN exome
AF:
0.169
Gnomad NFE exome
AF:
0.261
Gnomad OTH exome
AF:
0.239
GnomAD4 exome
AF:
0.250
AC:
365109
AN:
1460112
Hom.:
46821
Cov.:
32
AF XY:
0.248
AC XY:
179938
AN XY:
726430
show subpopulations
African (AFR)
AF:
0.305
AC:
10213
AN:
33446
American (AMR)
AF:
0.186
AC:
8324
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.257
AC:
6702
AN:
26120
East Asian (EAS)
AF:
0.182
AC:
7243
AN:
39688
South Asian (SAS)
AF:
0.187
AC:
16136
AN:
86202
European-Finnish (FIN)
AF:
0.173
AC:
9209
AN:
53322
Middle Eastern (MID)
AF:
0.298
AC:
1720
AN:
5768
European-Non Finnish (NFE)
AF:
0.262
AC:
290645
AN:
1110544
Other (OTH)
AF:
0.247
AC:
14917
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
14105
28210
42316
56421
70526
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9738
19476
29214
38952
48690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.255
AC:
38820
AN:
152132
Hom.:
5181
Cov.:
33
AF XY:
0.248
AC XY:
18430
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.311
AC:
12891
AN:
41480
American (AMR)
AF:
0.207
AC:
3167
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
867
AN:
3466
East Asian (EAS)
AF:
0.165
AC:
856
AN:
5176
South Asian (SAS)
AF:
0.172
AC:
832
AN:
4826
European-Finnish (FIN)
AF:
0.166
AC:
1756
AN:
10600
Middle Eastern (MID)
AF:
0.259
AC:
76
AN:
294
European-Non Finnish (NFE)
AF:
0.258
AC:
17516
AN:
67980
Other (OTH)
AF:
0.264
AC:
559
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1530
3059
4589
6118
7648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.196
Hom.:
658
Bravo
AF:
0.264
Asia WGS
AF:
0.204
AC:
708
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 31% of patients studied by a panel of primary immunodeficiencies. Number of patients: 30. Only high quality variants are reported. -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hyperimmunoglobulin D with periodic fever;C1867981:Porokeratosis 3, disseminated superficial actinic type;C1959626:Mevalonic aciduria Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.0010
DANN
Benign
0.41
PhyloP100
-6.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2270375; hg19: chr12-110024541; COSMIC: COSV57332948; COSMIC: COSV57332948; API